Cheapest compounded semaglutide telehealth in 2026: the verified low-cost list
The cheapest verified program is $129 a month, all in. But the headline number hides two things that change what you actually pay: dose tiering and supply risk. Here is the ranked list, with both spelled out.
The short answer. Of the programs we track that still dispense compounded semaglutide for cash, the lowest verified all-in price is Noom Med at $129 a month for its full-dose GLP-1Rx, billed quarterly with no lock-in. Strut Health and Klarity Health sit at $149 to $199 with no membership and no contract. Mochi Health charges a flat $178 at every dose, which is the cheapest option that does not climb as you titrate up. Below that floor, the prices you see advertised across the rest of the category almost always exclude something: the membership, the clinician visit, or the dose increase that lands in month three.
Compounded semaglutide is the same molecule as Wegovy at a fraction of the cost, dispensed by a 503A compounding pharmacy rather than Novo Nordisk. The price gap is real and large. The reason a "cheapest" list is worth writing carefully is that the compounded market in 2026 is unstable, and the lowest sticker price is frequently attached to the program with the most aggressive dose tiering or the shortest runway. We sorted for the price you actually pay at a maintenance dose, not the intro-month teaser.
| Fact | Value | Source | Verified |
|---|---|---|---|
| Cheapest verified all-in, full-dose compounded sema | $129/mo (Noom Med GLP-1Rx, billed quarterly) | Program pricing data | May 2026 |
| Cheapest flat price (no dose climb) | $178/mo (Mochi, same at every dose) | joinmochi.com | May 2026 |
| Typical compounded sema price band, injectable | $129 to $349/mo all-in | Program pricing data | May 2026 |
| Branded Wegovy cash floor for comparison | $349 to $499/mo (NovoCare direct) | novocare.com | May 2026 |
| FDA semaglutide shortage resolution | October 2024 (narrows the 503A legal basis) | FDA drug shortage list | May 2026 |
| Fastest verified time to prescription | 24 hours (Hims, Eden, Lindora) | Program onboarding data | May 2026 |
The cheapest compounded semaglutide programs, ranked
The table below sorts by the all-in monthly price a cash patient actually pays, lowest first. "All-in" means membership plus medication plus any visit fee. The form column matters: an oral lozenge at $149 is not the same product as an injectable at $149, and the injectable is what most patients want. The lock-in column flags whether the lowest price requires a commitment.
| Program | All-in / mo | Form | Lock-in | Time to Rx |
|---|---|---|---|---|
| Noom Med | $129 (full sema) | Injectable | Month-to-month | ~72 hrs |
| Strut Health | $149–$199 | Oral tablet / injectable | Month-to-month | ~48 hrs |
| Klarity Health | $150–$199 | Injectable | Per-visit | ~72 hrs |
| Ivim Health | ~$150 | Injectable | Prepay for the discount | ~72 hrs |
| Push Health | $150–$350 | Injectable (marketplace) | Pay-per-request | ~48 hrs |
| Mochi Health | $178 flat | Injectable | Month-to-month | ~48 hrs |
| Found | $189 cash | Injectable | 12-mo for lowest tier | ~72 hrs |
| Henry Meds | $197–$297 | Injectable | Month-to-month | ~48 hrs |
| Lemonaid Health | $278–$348 | Injectable | Per-visit | ~72 hrs |
All-in prices verified May 2026 against each program's published offer terms. This is the compounded-semaglutide cut of the 25 programs we track; the full comparison chart carries every program and lets you sort by price, lock-in, and medication type. See our methodology for how we verify.
Why $129 is not always the cheapest for you
The trap in every "cheapest semaglutide" list is that the lowest number is usually a starting dose, an intro month, or a non-injectable formulation. Three things separate a real low price from a teaser.
Dose tiering: the price that climbs as you titrate
Most compounded programs raise the medication price as your dose increases. Medvi is $179 in the first month and $299 on refills. Henry Meds runs $197 on a 12-month prepay at a standard dose and up to $397 at higher doses. A patient who budgets against the $197 line gets surprised at the 1.7 mg maintenance dose. The two programs that do not do this are Mochi at a flat $178 and Noom Med at a flat $129, where the price is the same at every dose. If you expect to titrate to a high maintenance dose, flat pricing wins even when its month-one number looks higher.
Form: injectable versus oral is not the same product
Some of the lowest advertised prices in the category are for oral compounded semaglutide, tablets, troches, or sublingual lozenges, not the injectable. Strut Health markets an oral tablet, and Eden leans on oral troches as a differentiator. Oral compounded semaglutide has a thinner clinical evidence base and a lower dose ceiling than the injectable. If the price looks unusually low, check whether it is a needle or a pill before you compare it to an injectable plan.
The membership you only see at checkout
Unbundled programs publish the medication price prominently and bill the membership separately. Lemonaid advertises compounded sema from $229 but adds a $49 monthly membership, landing the all-in at $278 to $348. Ivim reaches its ~$150 all-in only because the $75 medication and the $75 program fee are added together, and the discount requires a prepay. The number that matters is membership plus medication plus visit fee, ignoring the intro month. Our guide to how GLP-1 telehealth pricing works breaks down all four of these mechanisms.
The supply-risk discount nobody prices in
The reason compounded semaglutide is cheap is the same reason it is risky to plan a year around: it exists in a regulatory gap that is closing. The FDA removed semaglutide from its drug-shortage list in October 2024, which narrows the legal basis for routine 503A compounding. Most programs now operate under a "personalization claim," adding a second ingredient or a custom dose so the compound is not a straight copy of the branded drug. That ground is moving.
The practical consequence is that the cheapest program is not automatically the best buy if it is also the most exposed. Mochi lost a partner pharmacy to FDA enforcement in 2025 and is named in Lilly's compounded-tirzepatide litigation. Hims settled with Novo Nordisk in March 2026 and closed new compounded sign-ups, keeping only legacy patients. A program with clean enforcement history and a disclosed pharmacy partner is worth a few dollars a month over one that will not name its pharmacy. Before you sign up, ask which 503A pharmacy fills the prescription and what its most recent inspection found. A program that answers clearly is operating responsibly; one that calls it proprietary is a flag.
How to actually pick the cheapest one for your situation
- Estimate your maintenance dose, then read the price there, not at the start. If you expect to reach 1.7 mg or higher, a flat program like Mochi ($178) or Noom Med ($129) usually beats a tiered program that starts lower and climbs past $299.
- Confirm the form is injectable unless you specifically want oral. An oral lozenge at $149 is not comparable to an injectable at $149. Most evidence and most dose headroom sit with the injectable.
- Add up the whole bill. Membership plus medication plus any visit fee, ignoring the intro month. The real comparison is months two through twelve.
- Avoid prepay until you have tolerated a month. Roughly 10 to 15 percent of patients stop GLP-1s inside the first month over GI side effects. Found's lowest tier and Ivim's discount both require a commitment you cannot refund once medication ships.
- Ask which pharmacy fills it. A named 503A pharmacy with clean enforcement history is the difference between a stable supply and a sudden gap.
If price is your only filter, the order is clear: Noom Med at $129, then Strut and Klarity around $150, then Mochi's flat $178. If supply stability matters as much as price, Mochi's flat pricing and disclosed model make it the safer pick near the bottom of the range. The full price index shows the all-in monthly cost for every program side by side, and the comparison chart lets you sort by lock-in and medication type at once. If you would rather have a branded path with no supply risk, our LifeMD vs Hims cost comparison covers the two cheapest brand-only programs for new patients.
Frequently asked questions
What is the cheapest compounded semaglutide program in 2026?
Among the programs we track, Noom Med is the cheapest verified all-in price for full-dose injectable compounded semaglutide at $129 a month, billed quarterly with no lock-in. Strut Health and Klarity Health sit at $149 to $199 with no membership. Mochi at a flat $178 is the cheapest option whose price does not climb as you titrate up. Prices verified May 2026.
Why is compounded semaglutide so much cheaper than Wegovy?
It is the same active molecule, semaglutide, but dispensed by a 503A compounding pharmacy rather than manufactured and sold by Novo Nordisk. Compounded runs $129 to $349 a month all-in; branded Wegovy's cash floor through NovoCare direct is $349 to $499. The price gap reflects the manufacturing and distribution chain, not the molecule. See our compounded versus FDA-approved comparison for what is actually different.
Does the cheapest price go up as my dose increases?
At most programs, yes. Medvi goes from $179 to $299, and Henry Meds can reach $397 at higher doses. Two programs hold a flat price at every dose: Mochi at $178 and Noom Med at $129. If you expect a high maintenance dose, a flat program is usually cheaper over a year even if its starting number looks higher.
Is the lowest-priced compounded semaglutide safe?
Compounded semaglutide can be safe when it comes from a 503A pharmacy with clean enforcement history and disclosed sourcing. The documented risks are potency variation, salt-form substitution, and sterility failures at specific pharmacies, not the molecule itself. The cheapest program is not automatically the riskiest, but a low price attached to a program that will not name its pharmacy is a flag. Read our compounded safety analysis before choosing on price alone.
What happens if my cheap compounded program shuts down?
503A pharmacies can be closed by FDA or state-board action with little warning, and a few have been. Keep a 30-day buffer of medication where you can, and have a route to branded Wegovy through NovoCare direct at $349 to $499 or to insurance coverage if your supply halts. Our compounded-to-brand switch guide covers the transition.
Can I switch to a cheaper program without losing my dose?
Yes, if you document your current dose and time the move so your gap stays under 14 days. The new prescriber writes at your current dose rather than restarting titration when you provide proof, a pen label photo or a pharmacy receipt. Our guide on switching programs without losing continuity has the full sequence.
Is oral compounded semaglutide cheaper than the injectable?
Sometimes the headline price is lower, but it is a different product. Oral tablets, troches, and sublingual lozenges have a thinner clinical evidence base and a lower dose ceiling than the injectable. If a price looks unusually low, confirm whether it is a needle or a pill before comparing it to an injectable plan.
Related
Programs mentioned in this article
